Endogenous Cushing Syndrome
📧 Sign up to get email alerts when something new happens for Endogenous Cushing Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
Non-interventional study evaluating osilodrostat in patients with endogenous Cushing's syndrome is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
A clinical trial update evaluating a block-and-replace strategy using Osilodrostat with concurrent glucocorticoid replacement for endogenous…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome [Phase 4]
Clinical trial update indicating continuation of a rollover study for Endogenous Cushing Syndrome in a Phase 4 investigation; current status…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome. [Phase 3]
Phase 3 trial assessing safety and efficacy of levoketoconazole for endogenous Cushing's syndrome has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Treatment for Endogenous Cushing's Syndrome [Phase 3]
Phase 3 clinical trial update for a treatment of endogenous Cushing's syndrome has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-10-25FDA Approved: MIFEPRISTONE — Supplemental Application (Corcept Therapeutics Incorporated)
The FDA approved a supplemental application for mifepristone from Corcept Therapeutics, updating the drug's labeling/indication.